A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Clinical trial NCT07203404 · RECRUITING

Trial details

NCT number: NCT07203404
Sponsor: Nanjing Bioheng Biotech Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

SLE LN ANCA Associated Vasculitis ANCA-Associated Glomerulonephritis Anti-GBM Disease MN SSc IIM IgA Nephropathy

Start date: 2025-07-24
Primary completion: 2027-07-23
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.